Publications by authors named "Guilherme Trevizan Kortas"

Article Synopsis
  • * The researchers followed strict guidelines and identified 22 human trials focused on drug effects on craving symptoms while excluding unrelated studies andnon-English language articles.
  • * Pharmacological options mainly involve off-label drugs and cannabinoid treatments, showing promise but needing more research, alongside the importance of non-pharmacological interventions like psychotherapy and behavioral treatments.
View Article and Find Full Text PDF

(1) Background: The treatment of substance addiction is challenging and has persisted for decades, with only a few therapeutic options. Although there are some recommendations for specific treatments for Alcohol Use Disorder (AUD), there is no specific medication used to treat alcohol cravings, which could benefit millions of patients that are suffering from alcoholism. Cravings, or the urge to use drugs, refer to the desire to experience the effects of a previously experienced psychoactive substance.

View Article and Find Full Text PDF

This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities (SM), with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as inequalities in the access to health care services. It is alarmingly clear that SM report higher rates of morbidity if compared to the general population. Health care delivery inequalities have also been reported in this special population.

View Article and Find Full Text PDF

Immigration typically occurs from low- to high-income countries and regions. Unfortunately, these wealthier areas also have higher rates of cannabis use (e.g.

View Article and Find Full Text PDF

Background: About 30% of regular cannabis users report withdrawal symptoms on cessation of prolonged use, such as irritability, insomnia, decreased appetite, depressed mood, anxiety, and restlessness. However, among highly dependent and/or in-treatment users, the incidence of withdrawal can be even higher, reaching up to 50-95% of individuals. This syndrome was only recognized by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) as a diagnosis with specific criteria in 2013.

View Article and Find Full Text PDF